Formoterol + Fluticasone Propionate in pharma franchise in Nagaland

Formoterol + Fluticasone Propionate in PCD pharma franchise in Bengaluru

Formoterol + Fluticasone Propionate in top pharma company in Aurangabad

Formoterol + Fluticasone Propionate in pcd pharma supplier in Hubli-Dharwad

Formoterol + Fluticasone Propionate in phama franchise company in India
Formoterol + Fluticasone Propionate in phama distributor in Sangli

Flutialfa F 250 Inhaler

Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)

Dosage Form : Inhaler

Packaging Type : Metered Dose with Carton and Leaflet

Packaging : 120

Price : ₹848/-

Please Contact For Best Price

Flutialfa F 250 Inhaler is a combination medication that contains Formoterol (6mcg), a long-acting beta-agonist (LABA), and Fluticasone Propionate (250mcg), a potent corticosteroid. This inhaler is specifically designed for the management of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). Formoterol works by relaxing the muscles of the airways, allowing them to open up, which helps improve airflow to the lungs. Fluticasone Propionate reduces inflammation within the airways, preventing the occurrence of asthma attacks or exacerbations in COPD patients.

The combination of these two medications in Flutialfa F 250 Inhaler ensures both long-term bronchodilation and anti-inflammatory effects, providing a comprehensive treatment for patients with asthma and COPD. This inhaler is used as a maintenance therapy to control symptoms, reduce the frequency of exacerbations, and improve overall lung function. It is not intended for immediate relief of acute asthma attacks or COPD flare-ups.

Read More

About the Product

Flutialfa F 250 Inhaler is a combination medication that contains Formoterol (6mcg), a long-acting beta-agonist (LABA), and Fluticasone Propionate (250mcg), a potent corticosteroid. This inhaler is specifically designed for the management of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). Formoterol works by relaxing the muscles of the airways, allowing them to open up, which helps improve airflow to the lungs. Fluticasone Propionate reduces inflammation within the airways, preventing the occurrence of asthma attacks or exacerbations in COPD patients.

The combination of these two medications in Flutialfa F 250 Inhaler ensures both long-term bronchodilation and anti-inflammatory effects, providing a comprehensive treatment for patients with asthma and COPD. This inhaler is used as a maintenance therapy to control symptoms, reduce the frequency of exacerbations, and improve overall lung function. It is not intended for immediate relief of acute asthma attacks or COPD flare-ups.

Common side effects include headache, throat irritation, hoarseness, and tremors. Rare but serious side effects may include oral candidiasis (thrush), heart palpitations, or signs of an allergic reaction (rash, swelling).

Flutialfa F 250 Inhaler is indicated for: Asthma: Maintenance treatment for asthma in adults and children (over 12 years) to prevent symptoms and improve lung function. Chronic obstructive pulmonary disease (COPD): Used to reduce exacerbations and manage chronic symptoms of COPD.

This inhaler is for maintenance therapy only and should not be used to relieve acute symptoms. Rinse your mouth after each use to prevent oral thrush. If symptoms persist or worsen, consult your healthcare provider immediately.

Store Flutialfa F 250 Inhaler in a cool, dry place at room temperature (between 15°C to 30°C). Keep the inhaler away from direct sunlight and moisture. Do not refrigerate or freeze the inhaler. Keep it out of the reach of children.

Get in Touch